Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Short sellers made bold moves in the past week. Braveheart Bio saw the most dramatic shift, with SI jumping to 691% of free float from 367% seven days ago. That is a 324-point surge. The stock is a pharmaceutical name with a $1.5bn market cap, and bears are loading up hard.
MiniMed Group also drew fresh interest. SI climbed to 77% of free float, up from 42% a week ago. With a short score of 91, shares available to borrow are nearly zero at 1% availability. That combination makes a squeeze increasingly plausible.
Lucid Group added 8 percentage points to reach 58% SI of free float. The EV maker has been a consistent short target. Bears see no near-term catalyst to change course.
Globant is a surprise mover. The IT services firm saw SI rise from 20% to 30% in a week. That is a notable new bet against a stock not usually in bearish crosshairs.
On the cover side, Chewy saw shorts pull back sharply. SI dropped from 75% to 67% in seven days. Bears may be rethinking a position that has sat elevated for months.
1-800-Flowers continues to look squeezable. SI sits at 79% of free float with days-to-cover above 33. Availability is thin at 24%. Any positive catalyst could trigger a painful unwind.
Taiwan's August export orders hit a record $103bn, up 71% year-on-year per ORTEX alt data. That backdrop gives chip-adjacent longs ammunition against a crowded short book in names like Wolfspeed, where SI remains above 81% of float.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
